# OnCo record rejuv-tx-revaccination (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/rejuv-tx-revaccination/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "rejuv-tx-revaccination" ;
  schema:name "Revaccination after transplant: the schedules, and where the UK and the US differ"@en ;
  schema:alternateName "re-immunisation after HSCT"@en, "post-transplant vaccination schedule"@en, "ECIL-7 vaccination"@en, "Green Book chapter 7"@en ;
  schema:description "A transplant erases the protection built up by a lifetime of vaccinations, including childhood ones, and it has to be rebuilt. Published schedules exist, the vaccines are free at the point of use in the NHS, and the usual failure is that nobody writes the plan down. If you have had a transplant and have no written schedule, ask for one."@en ;
  schema:url <https://onco.cc/technologies/rejuv-tx-revaccination/> ;
  schema:dateModified "2026-10-02"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Vaccination> ;
  schema:citation <https://doi.org/10.1016/S1473-3099(18)30600-5>, <https://www.gov.uk/government/publications/immunisation-of-individuals-with-underlying-medical-conditions-the-green-book-chapter-7>, <https://doi.org/10.1016/j.jinf.2022.11.005>, <https://www.cdc.gov/vaccines/hcp/imz-best-practices/altered-immunocompetence.html>, <https://doi.org/10.1093/cid/cit684>, <https://bsbmtct.org/bsbmtct-guidelines/> ;
  onco:status "standard-of-care" ;
  onco:tag "rejuvenation", "survivorship", "transplant", "evidence:strong", "immune", "vaccination" ;
  onco:related <https://onco.cc/technologies/rejuv-frontier-immune-reconstitution/>, <https://onco.cc/technologies/rejuv-tx-immune-reconstitution-timeline/>, <https://onco.cc/technologies/rejuv-tx-infection-by-phase/>, <https://onco.cc/technologies/rejuv-tx-b-cell-aplasia-and-immunoglobulin/>, <https://onco.cc/technologies/rejuv-tx-what-to-ask-for/>, <https://onco.cc/terms/lymphoma-living-vaccinations/> ;
  onco:sections <https://onco.cc/fronts/rejuvenation/>, <https://onco.cc/fronts/supportive-care/> ;
  onco:technologies <https://onco.cc/technologies/allogeneic-hsct/>, <https://onco.cc/technologies/autologous-stem-cell-transplant/>, <https://onco.cc/technologies/car-t/>, <https://onco.cc/technologies/survivorship-care-plan/> ;
  onco:drugs <https://onco.cc/drugs/human-normal-immunoglobulin/>, <https://onco.cc/drugs/rituximab/> ;
  onco:terms <https://onco.cc/terms/late-effects/>, <https://onco.cc/terms/hypogammaglobulinaemia/>, <https://onco.cc/terms/gvhd/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-survivorship/> .